Medical Technology is now available on all devices! Read it here for free in the web browser of your computer, tablet or smartphone.
Blood pressure is a key bio marker in most clinical trials, offering important insight into a patient’s health and the performance of a drug candidate. As such, getting the most accurate reading is the essential. As part of a new consortium led by Tyndall National Institute, Ireland based dabl, is participating in a new project to develop health tech solutions based on emerging human-centric intelligent sensors. We explore how these smart wearables could disrupt blood management in clinical trials.
Also in this issue, we profile prominent technological developments enabling stronger and superior bone remodelling, find out what can be done to fix the medical industry’s software development deficit, and examine innovative alternatives to battery powered medical implants that use the human body to reduce the reliance on onboard batteries.
Plus, we explore the challenges of treating illness and injury in space, could 3D printing medical materials provide a solution for astronauts on long space missions, and ask if a single, harmonised auditing system for medical device manufacturing could grow into an extra regulatory layer with a global scope.
And, as always, we round up the latest news from the medical device industry, and get comment and analysis from GlobalData’s healthcare analysts.
In this issue
Smart wearables for blood pressure management
Ireland based dabl, which specialises in blood pressure management and data analysis, is participating in a new project to develop health tech solutions based on human-centric intelligent sensors. Abi Millar caught up with dabl to learn more about the potential of wearables in blood pressure monitoring.
To the bone: improving scaffolds using 3d printing
Bone remodelling and regeneration following trauma has been traditionally supported by scaffolds created from patient’s bone cells with disappointingly variable levels of success. To find a better solution, researchers are looking at new technologies and tissue engineering approaches, of which 3D printing seems to hold great promise. Allie Nawrat reports.
Is software a blind spot for the medical device industry?
Software is driving incredible advancements in medical technology and opening up exciting opportunities for decentralised healthcare. But, at the same time software is also the leading cause of device recalls and failures prompting calls for a shift in focus. Has there been too much focus on hardware? Chris Lo reports.
Low battery: finding alternative ways to power medical devices
Relying on batteries that will eventually run out or require invasive wiring is a major barrier to medical device innovation. A handful of research projects are however focused on alternate means of power, but what are the obstacles they will have to overcome? Allie Nawrat finds out.
3D printing medical devices in space
Astronauts face serious health issues, including hand injuries and risk of infection during long duration space missions far from earth. Chile-based Copper 3D has received funding from NASA to test a new, 3D printing-based approach adapted for the unique space environment. Allie Nawrat finds out more.
MDSAP: unifying monitoring of medical device manufacturing
The MDSAP aims to create a harmonised, global approach to auditing and monitoring of medical device manufacturing. This approach could be of huge benefit to medical device companies as it allows them to expand easily into new markets, but how wide is its scope? Allie Nawrat reports.
Next issue preview
The US Food and Drug Administration has come up with draft guidance to help promote the development of brain-computer interface devices, which could allow users to control implants directly. We explore the issues surrounding the emerging area of innovation.
Also, we find out what it takes for medtech start-ups to crack the UK’s all-important NHS market, unlock the secrets behind the impressive performance of Israel’s medical technology market, and take a look at the pros and cons of the US’s levy on medical device sales.
Plus, we investigate a lack of transparency surrounding the FDA’s reporting of medical device failures and take a look at the science behind breath biopsies.